Literature DB >> 884792

The Erysichthon syndrome. Progression of coronary atherosclerosis and dietary hyperlipidemia.

D T Nash, G Gensini, H Simon, T Arno, S D Nash.   

Abstract

One hundred nineteen patients with coronary artery disease confirmed by coronary arteriograms were studied. Cine coronary arteriography confirmed progression of atherosclerosis in 106 (89%) patients (mean age 50.9 yr) and nonprogression in 13 (11%) patients (mean age 50.3 yr). Progression was defined as follows: any increase to 50% stenosis, 50% to 75% narrowing, 75% to 90%, 90% to 99%, 99% to total occlusion. Only one patient of the 106 who progressed (less than 1%) had ideal values for both cholesterol and triglyceride. Three of 13 patients (23%) who did not progress had ideal lipid values (P less than 0.005). Fifty four of 106 patients who progressed had cholesterol levels greater than or equal to 250 mg%; none of 13 patients who did not progress had such levels (P less than 0.005). Thirty-nine of 98 (40%) patients who progressed had hypertension; only one (8%) who did not progress had hypertension (P less than 0.025). Seventy-four of 96 patients who progressed were smokers (77%); two of 13 nonprogression patients smoked (15%) (P less than 0.005).

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 884792     DOI: 10.1161/01.cir.56.3.363

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

1.  Gluten sensitivity: new epidemic or new myth?

Authors:  David T Nash; Amy R Slutzky
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-10

2.  Coronary artery bypass grafting and hyperlipidaemia.

Authors:  G Thompson; R Sapsford
Journal:  Br Heart J       Date:  1985-03

3.  The progression of coronary artery disease.

Authors:  M C Petch
Journal:  Br Med J (Clin Res Ed)       Date:  1981-10-24

4.  Effects of therapy with diet and simvastatin on atherosclerosis in hypercholesterolemic patients.

Authors:  C W Barlow; B M Friedman; D P Myburgh; E R Soicher; W F Steenkamp; D H Smith
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727

5.  International nifedipine trial on antiatherosclerotic therapy (INTACT).

Authors:  P R Lichtlen; U Nellessen; W Rafflenbeul; S Jost; H Hecker
Journal:  Cardiovasc Drugs Ther       Date:  1987       Impact factor: 3.727

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.